The Alkaline Water Company Inc.

For the three months ended September 30, 2022, revenue was approximately $19.6 million versus $15.3 million a year ago, up 28%. Gross profit was approximately $4.6 million, or 23.6% of sales, compared with approximately $5.2 million in the prior-year quarter; gross margin improved from 20.7% in Q1 to 23.6% in Q2. Total operating expenses were approximately $9.7 million versus $15.4 million last year, and operating loss improved to approximately $5.1 million from $10.2 million. Net loss was $8.4 million, or $0.06 per share, versus a $10.4 million loss, or $0.11 per share, last year. Cash at quarter-end was approximately $2.3 million. Management did not give formal next-quarter or full-year revenue guidance, but said gross margin is expected to build to about 26% to 27% in Q3 and 29% to 30% in Q4, and reiterated the year-end goal to reduce inventory by $2 million from the start of Q2.

Frank Lazaran framed the quarter as proof that the company is moving onto a “Pathway to Profitability” while still delivering record top-line growth. He emphasized operational discipline: lower G&A, lower freight, vendor negotiations, inventory reduction, and a broader $20 million pool of identified cost savings and margin enhancements. His tone was constructive and confident, but he repeatedly noted that the margin recovery and efficiency gains will take time to fully flow through.

David Guarino focused on the reported financials: revenue of about $19.6 million, gross profit of about $4.6 million, gross margin of 23.6%, operating expenses of about $9.7 million, operating loss of about $5.1 million, and net loss of $8.4 million or $0.06 per share. He explained that gross margin pressure came from higher raw material and shipping costs, and he noted a roughly $3 million non-cash other expense tied to debt conversion and warrant exercise activity; without that charge, net income improvement would have been about $5 million. He also said cash ended at about $2.3 million and that current cash, the line of credit, and the ROTH Capital sales agreement are expected to fund operations, though the company may seek additional equity, debt, or strategic investment if plans change or capacity is expanded.

There was no substantive analyst Q&A in the transcript, so no specific analyst concerns or follow-up management answers were captured. The closest guidance-like comments came from management’s discussion of margin targets, inventory reduction, and the expected closing of $6 million to $7 million of non-dilutive funding by year-end. Management also addressed liquidity by saying current funding sources should support operations, while acknowledging the possibility of additional capital if needed.